with diabetes are able to care for and manage their disease. 4 Structured self-monitoring using an in-home bG meter not only provides a way for the patient to track his/her bG, but allows the patient to manage the disease by observing the metabolic fluctuations induced by food intake, physical activity, stress or fever, or the development of hypoglycemia. 4 The frequency and timing of self-monitoring of bG is different for each individual based on the unique manifestation of the disease, doctor recommendation, and the willingness of the patient to use the meter. 5 Despite an individualized regimen of bG testing, sometimes patients do not test their bG as frequently as recommended because of the inconvenience and discomfort of testing or because of testing errors despite the proven accuracy of the meter. 4 In addition to regular testing, patients are encouraged to measure bG when there is a suspicion of a hypoglycemia, since data suggest the prevalence of hypoglycemia results is a major cardiovascular risk. 6 However, testing under hypoglycemic conditions sometimes results in testing errors since hand-eye coordination is often diminished.
While inconvenience and discomfort are an inherent part of the management of the disease, reduction in the frequency of errors can be addressed. While technical advances have greatly reduced mechanical errors in the accuracy of the meters, research indicates that user error, not mechanical error, is the biggest source of inaccurate bG readings. 4, 7 In 1 study by Colagiuri et al, 8 62% of patients made at least 1 "clinically significant" error, with "faulty technique" being cited as the cause for most errors. Another study found that roughly 75% of the errors made could be traced back to user error; the most common source of error in this study was correct application of blood to the test strip. 9 While these studies were conducted on older generations of meters than the one being tested, user errors still exist today. 10 Increased usability of the bG meter and test strips could play a role in patients' willingness and ability to accurately test according to the doctor recommended regime. 11 Several known handling problems in meter system designs resulting in errors in bG testing are identified in Table 1 .
In the past, usability was not necessarily a primary goal when developing and testing new medical devices, but the publication of "Medical Devices-Application of Usability Engineering to Medical Devices" 16 has led to a new push to develop medical devices that are both safe and easy to use. Usability engineering, a technique that relies on user input in the early stages of development to improve the design of a product, is especially important in the field of diabetes management because diabetes patients have a greater role in self-management and decision making than in most other medical conditions. 17 After accuracy, ease of use was the second most important attribute to be considered when purchasing a bG meter. 4 Usability testing prior to releasing a new bG meter on the market can help clarify user constraints, wants, and capabilities, as well as design out potential errors and identify important user needs, thus enabling patients to follow their doctor-recommended testing regimen in the easiest and most accurate way possible. 17 In addition to ease of use and reduction of user error relating to testing bG, incorporating other features to allow a user to keep track of results, provide recommended insulin doses, and identify overall trends in bG readings as well as connectivity to a smartphone could also encourage consistent use of the meter for better diabetes management. 18
Methods
Louisiana State University in conjunction with Roche Diabetes Care, Inc conducted a human factors usability claims validation study of the Accu-Chek® Guide Meter System designed to address the common handling problems previously listed in Table 1 . The study focused on several new features of the system that are intended to reduce the occurrences of common handling problems. For example, the design of the strip vial prevents strips from spilling, and the strip has a large dosing target. The meter itself includes an ejection button for strip removal as well as a light illuminating the strip port. The pattern detection and data management on both the meter and via wireless connectivity to a smart phone allow the user to view current and past results, trends in bG readings, and obtain insulin bolus advice. Images of the meter, strip vial, and smartphone app are shown in Figure 1 .
The objective of this study was to evaluate the participants' perceived usability (level of agreement/disagreement) of the meter after performing some typical tasks that include performing bG testing, use of the pattern detection feature, and the review of data on both the meter and with the mobile app. The study was broken down into the 3 phases shown in Figure 2 . Following each phase, participants were asked to complete a series of usability statement questions using a 6-point agree/disagree scale.
Participants
A total of 197 participants from the United States and France met the following basic inclusion criteria:
a. Be insulin dependent and inject insulin at least 1 time per day b. Perform all bG meter tasks on their own (no extreme visual or dexterity impairments) c. Test bG at least 2 times a day Participants were roughly evenly divided by gender. The age range was 18-69 years old with approximately 50% of the total participants falling into the 35-59 years age group. More than 70% of the participants were considered technologically adept (defined as using a smartphone and downloading at least 1 application in the past 6 months and using apps at least 1 time per week). Table 2 shows the breakdown by current meter brand being used by participants with 76% of users having used their current meter for 5 years or less.
Statistical Analysis
A 6-point rating scale was used where quite agree is the positive side of scale with a value of 6 and substantially disagree is the negative side of scale with a value of 1. The ratings were split into binary responses with quite agree, moderately agree, and perhaps agree representing a positive response and substantially disagree, moderately disagree, and perhaps disagree representing a negative response. These terms have been psychometrically determined to be equal distance apart from one another. 19 In addition, the lack of a middle point ensured that users chose a positive or negative response. This allowed for the positive and negative sides of the scale to be collapsed and compared for each statement. This approach determined the proportion of the sample that agreed versus disagreed with each statement. A Pearson chi-square proportions test was used to determine if the proportions of the responses to the 2 sides of the scale are significantly different from one another. An α of .05 was assumed for all testing.
Results
The first step in performing the proportions test was to combine the data from both the US and the French testing locations and group the data into agree and disagree binary responses. The proportions test only evaluates the number of agree and disagree statements and not the level of those measures. The total number of participants (N) was 105 from the United States and 92 from France for a total of 197 for most questions, except where a participant failed to mark a response. Results of a Pearson chi-square proportions test showed a significant difference (P < .0001) between the disagree responses (1-3) and agree responses (4-6) for all statements in each phase (Figures 3 and 4) . These results show that significantly more people rated each statement on the agree side of the scale than the disagree side of the scale. Above is a summary of the proportions testing broken down by statement showing the percentage of answers for each response category.
Discussion
Proportions test results showed that for all statements, regardless of country, significantly more participants agreed with the usability statement questions than disagreed. A total of 95% or more of participants agreed with 21 out of a possible 34 statements. For all 11 statements related to guidance and advice in Phase III (Q6a-c), more than 95% of the participants agreed with the statements. This indicates that guidance and advice available on both the meter and the mobile app is of vital importance and participants found the guidance and advice features to be much attuned to their needs. Only 4 statements out of 34 resulted in less than 90% of the participants agreeing with the statement questions; however, the proportion who agreed was still significantly more than those who disagreed. Incidentally, these 4 statements were the only statements comparing the meter system to the participants' current system (applying blood, removing a strip from the container, and performing quick/easy bG test). These statements also appeared during the Phase I of the session, which means participants only had limited interaction (usually less than 20 minutes in duration and performed 3 bG tests) with the new device before responding to the statements. When one considers that the participants have been using their current meter potentially for many years and were exposed to the meter only for less than an hour, achieving 84-90% agreement on these 4 statements speaks highly of the usability of the meter. Overall, these results indicate that the participants significantly agreed with all of the usability statement questions made by the meter.
Additional grouping was done for 2 statements in question 1 to determine how many users found that the strip made it easier and faster to correctly place a small blood drop on the end of the strip. Results showed that 93% of users (184 out of 197) agreed with both statements 1A and 1B. In addition, 2 statements in question 3 were combined to see how many users found that checking bG levels with the meter was easier and faster than with the participant's current system. Results of this grouping showed that 83% (163 out of 197) of participants agreed with both statements 3B and 3C. In each case, the proportion who agreed with both statements was significantly different than those who disagreed with one or both statements.
Last, analysis of variance (ANOVA) was used to determine if current meter brand resulted in any significant difference in response to any questions. Results of this analysis found that there was no significant difference in any question for either France or the United States based on the participants' current brand of meter. This result indicates that participants did not rate any question differently based on their current meter brand.
Conclusion
A discrete, comfortable, and easy-to-use bG self-management system is the key to successful diabetes management. Designing meters that take usability into consideration can help people with diabetes better manage the disease. Trying to address some of the most common handling problems, the meter was developed and then tested by current diabetes patients for usability. User responses to the meter were extremely positive when reviewed using proportions testing. An overwhelming majority of participants found the meter, including the test strips and strip vial, to be a good fit for their lifestyle and provides a better testing experience compared to their current systems. Participants were able to successfully use the meter and the features with very little training or exposure to the meter regardless of the brand of their current meter. The pattern detection and guidance features available on the meter and the mobile app were also very well received by most of the participants indicating that these state-of-theart features are a necessary step in effective diabetes care management in the future. The meter, Accu-Chek Guide, was found to have superior usability over the participants' current meters in both the United States and France.
